Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 15/20 | 0.69 |
| ▸ | CA9 | Q16790 | 13/20 | 0.69 |
| ▸ | ELANE | P08246 | 2/20 | 0.69 |
| ▸ | CA2 | P00918 | 6/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9831972 | 0.86 | CA12 (0.71) | CA12CA9ELANECA2NPC1 | |
| SCHEMBL6958970 | 0.83 | CA12 (0.71) | CA12CA9ELANECA2 | |
| SCHEMBL17329453 | 0.82 | CA9 (0.73) | CA12CA9ELANECA2 | |
| SCHEMBL7281348 | 0.81 | CA12 (0.69) | CA12CA9ELANECA2 | |
| SCHEMBL5899155 | 0.81 | ELANE (1.00) | CA12CA9ELANECA2 | |
| SCHEMBL7290973 | 0.81 | CA12 (0.69) | CA12CA9ELANECA2 | |
| SCHEMBL1101896 | 0.81 | CA12 (1.00) | CA12CA9ELANECA2 | |
| SCHEMBL7290946 | 0.81 | CA12 (0.69) | CA12CA9ELANECA2 | |
| SCHEMBL8865776 | 0.81 | CA12 (0.69) | CA12CA9ELANECA2 | |
| SCHEMBL30834902 | 0.81 | CA12 (1.00) | CA12CA9ELANECA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968751-B2 | Method of fluorination | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2011-06-28 | — | — | US | claimed |
| EP-2189466-A2 | METHOD OF FLUORINATION BY MICROWAVES | Mitsubishi Gas Chemical Company, Inc. (JP) | 2010-05-26 | — | — | EP | claimed |
| US-20080319228-A1 | Method of fluorination | HARA SHOJI | 2008-12-25 | — | — | US | claimed |
| EP-0106772-B1 | THERMOGRAPHIC COMPOSITIONS CONTAINING THESE DEVELOPERS AND THERMOGRAPHIC COPYING MATERIALS | AUSSEDAT-REY (FR) | 1987-03-25 | — | — | EP | claimed |
| US-4536219-A | SACCHARIN DERIVATIVES AS DEVELOPERS | SOCIETE ANONYME: AUSSEDAT-REY (FR) | 1985-08-20 | — | — | US | claimed |
| WO-2025260159-A1 | ISOINDOLINE AND INDOLINE DERIVATIVE COMPOUNDS, COMBINATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICAMENTS, USE OF THE COMPOUNDS AND METHOD OF TREATMENT OF PAIN | MICROBIOLÓGICA QUÍMICA E FARMACÊUTICA LTDA. (BR) | 2025-12-26 | — | — | WO | disclosed |
| CN-103328400-B | Glass fiber bundling agent and glass fiber reinforced crystalline resin composition | ADEKA CORP. (JP) | 2015-12-02 | — | — | CN | disclosed |
| US-8980163-B2 | Process for producing plastic bottle | ADEKA CORPORATION (JP) | 2015-03-17 | — | — | US | disclosed |
| EP-2423260-B1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | ADEKA CORP (JP) | 2013-12-04 | — | — | EP | disclosed |
| CN-103328400-A | Glass fiber bundling agent and glass fiber reinforced crystalline resin composition | ADEKA CORP | 2013-09-25 | — | — | CN | disclosed |
| EP-2423260-A1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | Adeka Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120013049-A1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | ADEKA CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
| EP-0483928-A1 | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use | STERLING WINTHROP INC. (US) | 1992-05-06 | — | — | EP | disclosed |
| EP-0471756-A4 | SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF | — | 1992-04-08 | — | — | EP | disclosed |
| EP-0471756-A1 | SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF. | STERLING WINTHROP INC (US) | 1992-02-26 | — | — | EP | disclosed |
| EP-0253092-B1 | 1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTITHROMBOTIC DRUGS | ALTER, S.A. (ES) | 1991-09-25 | — | — | EP | disclosed |
| WO-1990013549-A1 | SACCHARIN DERIVATIVES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND PREPARATION THEREOF | STERLING WINTHROP INC. (US) | 1990-11-15 | — | — | WO | disclosed |
| US-4782069-A | INHIBITION OF PLATELET ACTIVATION | ALTER, S.A. (ES) | 1988-11-01 | — | — | US | disclosed |
| US-4629683-A | STORAGE STABILITY AND TIMELY RELEASE OF PHOTOGRAPHICALLY USEFUL AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1986-12-16 | — | — | US | disclosed |
| US-4536219-A | SACCHARIN DERIVATIVES AS DEVELOPERS | SOCIETE ANONYME: AUSSEDAT-REY (FR) | 1985-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319228-A1 | Method of fluorination | FUCA2, FABP2, FGB | CA12 119/4885CA9 689/4885ELANE 2066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.